Retrospective cohort study of novel oral agents lenalidomide and duvelisib for relapsed or refractory mycosis fungoides and Sézary syndrome. - Elghawy O; Yang AG; Sussman JH; Thomas CJ; Carter JS; Landsburg DJ; Svoboda J; Kim E; Rook AH; Chung J; Villasenor-Park J; Plastaras JP; et al. (Journal of the American Academy of Dermatology, 2025)